|Articles|September 20, 2022
Cognizant's Shared Investigator Platform Grows to More Than a Quarter Million Users Globally
SIP SaaS solution has surpassed 250,000 users across 100 countries worldwide.
Advertisement
Cognizant announced that its Shared Investigator Platform (SIP), a life sciences Software as a Service (SaaS) solution that streamlines clinical trials, has surpassed 250,000 users across 100 countries worldwide. This digital platform facilitates research and collaboration by allowing clinical study documents and safety notifications to be exchanged across site and sponsor teams.
Read more about the platform
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
NIMBLE Trial Reveals New Insights on Complement Inhibition in gMGSeptember 15th 2025
Q&A: Strategies for Successful Global Clinical Trial DeliverySeptember 12th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research
2
Phase IV Trial Shows Daybue Demonstrates Real-World Behavioral Improvements in Rett Syndrome
3
Capvaxive Demonstrates Robust Immune Responses in Children, Adolescents at Increased Risk of Pneumococcal Disease
4
Merck Reports Strong Phase II Results for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
